Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $9.23 and traded as high as $9.39. Bavarian Nordic A/S shares last traded at $9.29, with a volume of 4,552 shares changing hands.
Bavarian Nordic A/S Stock Down 3.4 %
The business's 50-day simple moving average is $9.20 and its two-hundred day simple moving average is $10.05. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 13.00 and a beta of 1.65.
Bavarian Nordic A/S Company Profile
(
Get Free Report)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Further Reading
Before you consider Bavarian Nordic A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic A/S wasn't on the list.
While Bavarian Nordic A/S currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
